吉西他滨联合顺铂治疗晚期胆系肿瘤的近期疗效和安全性观察 |
| |
引用本文: | 杨爱荣.吉西他滨联合顺铂治疗晚期胆系肿瘤的近期疗效和安全性观察[J].现代保健,2014(32):106-109. |
| |
作者姓名: | 杨爱荣 |
| |
作者单位: | 青海大学附属医院,青海西宁810001 |
| |
摘 要: | 目的:探讨吉西他滨联合顺铂治疗晚期胆系肿瘤的疗效及相关不良反应。方法:2008年1月-2012年12月本科收治的经病理确诊为晚期胆道系统恶性肿瘤26例,给予吉西他滨1000 mg/m^2,静脉滴注,第1、8天;顺铂75 mg/m^2,静脉滴注,第1天,每21天为一周期。结果:吉西他滨联合顺铂治疗晚期胆系肿瘤的客观有效率为34.6%(9/26),疾病控制率为73.1%(19/26),其中CR 1例,PR 8例,SD 10例,PD 7例;化疗后主要不良反应为恶心呕吐(21例,80.8%)、白细胞减少(18例,69.2%)、血小板减少(12例,46.2%)、血红蛋白减少(10例,38.5%)、肝功能损害(11例,42.3%)、口腔黏膜炎(8例,30.8%)、肾功能损害(5例,19.2%)、腹泻(5例,19.2%),均在可耐受范围。结论:吉西他滨联合顺铂治疗晚期胆道系统肿瘤有效,不良反应较轻,安全性良好。
|
关 键 词: | 吉西他滨 顺铂 胆系肿瘤 化疗 |
Efficacy and Safety of Combination Therapy of Gemcitabine and Cisplatin for Advanced Biliary Tract Cancer |
| |
Authors: | YANG Ai-rong |
| |
Institution: | YANG Ai-rong(The Affiiated Hospital of Qinghai University, Xining 810001, China) |
| |
Abstract: | Objective:To investigate the efficacy and safety of combination therapy of gemcitabine and cisplatin for advanced biliary tract cancer.Method:A total of 26 cases of advanced biliary tract cancer in our hospital from January 2008 to December 2012 accepted combination therapy of gemcitabine(1000 mg/m^2,intravenous infusion 30 min,qd,d1、8) and cisplatin(75 mg/m^2, intravenous infusion,qd,d1) every 21-day cycle. Result:The objective response rate of combination therapy of gemcitabine and cisplatin was 34.6%(9/26), disease control rate was 73.1%(19/26), including CR 1 case, PR 8 cases, SD 10 cases, PD 7 cases. The major adverse reactions were nausea and vomiting(80.8%),leukopenia(69.2%),thrombocytopenia(46.2%),hemoglobin decreased(38.5%), hepatic dysfunction(42.3%),oral mucositis(30.8%),renal dysfunction(19.2%),diarrhea(19.2%). Conclusion:The combination thrapy regime with gemcitabine and cisplatin is recommended for patients with advanced biliary tract cancer,which is effective and safe. |
| |
Keywords: | Gemcitabine Cisplatin Biliary tract cancer Chemotherapy |
本文献已被 维普 等数据库收录! |
|